OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Agnes Shanley is senior editor of Pharmaceutical Technology.
The industry is moving beyond cleaning’s “low tech” image to embrace science-based limits and statistical approaches to control.
More collaboration and a knowledge-based approach, driven by better analytics and high-throughput system integration, are reducing the risk of failure.
Branching out from roots in industrial biotechnology, Riffyn Data Systems (and its CEO Tim Gardner) is taking the message of data-driven process improvement to biopharma.
Manufacturers and the US government are investing heavily in traditional and non-traditional forms and materials to ensure supplies of containers and delivery devices for COVID-19 treatments and vaccines.